247 related articles for article (PubMed ID: 15368349)
1. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
[TBL] [Abstract][Full Text] [Related]
3. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.
Roy M; Reiland J; Murry BP; Chouljenko V; Kousoulas KG; Marchetti D
Neoplasia; 2005 Mar; 7(3):253-62. PubMed ID: 15799825
[TBL] [Abstract][Full Text] [Related]
4. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
5. Selective heparanase localization in malignant melanoma.
Murry BP; Greiter-Wilke A; Paulsen DP; Hiatt KM; Beltrami CA; Marchetti D
Int J Oncol; 2005 Feb; 26(2):345-52. PubMed ID: 15645118
[TBL] [Abstract][Full Text] [Related]
6. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.
Uno F; Fujiwara T; Takata Y; Ohtani S; Katsuda K; Takaoka M; Ohkawa T; Naomoto Y; Nakajima M; Tanaka N
Cancer Res; 2001 Nov; 61(21):7855-60. PubMed ID: 11691803
[TBL] [Abstract][Full Text] [Related]
7. HPSE-1 expression and functionality in differentiating neural cells.
Moretti M; Sinnappah-Kang ND; Toller M; Curcio F; Marchetti D
J Neurosci Res; 2006 Mar; 83(4):694-701. PubMed ID: 16429446
[TBL] [Abstract][Full Text] [Related]
8. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
9. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
10. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells.
Yang YM; Dolan LR; Ronai Z
Oncogene; 1996 May; 12(10):2223-33. PubMed ID: 8668349
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
13. Heparanase expression and function during early pregnancy in mice.
D'Souza SS; Daikoku T; Farach-Carson MC; Carson DD
Biol Reprod; 2007 Sep; 77(3):433-41. PubMed ID: 17507691
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
15. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family.
Jean D; Bar-Eli M
Mol Cell Biochem; 2000 Sep; 212(1-2):19-28. PubMed ID: 11108132
[TBL] [Abstract][Full Text] [Related]
19. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
